165 related articles for article (PubMed ID: 34966411)
1. Role of the CBX Molecular Family in Lung Adenocarcinoma Tumorigenesis and Immune Infiltration.
Zhang C; Chang L; Yao Y; Chao C; Ge Z; Fan C; Yu H; Wang B; Yang J
Front Genet; 2021; 12():771062. PubMed ID: 34966411
[No Abstract] [Full Text] [Related]
2. Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma.
Li Q; Fu L; Wu D; Wang J
J Gastrointest Oncol; 2021 Oct; 12(5):2310-2324. PubMed ID: 34790394
[TBL] [Abstract][Full Text] [Related]
3. Diverse CBX family members as potential prognostic biomarkers in non-small-cell lung cancer.
Xie X; Ning Y; Long J; Wang H; Chen X
FEBS Open Bio; 2020 Oct; 10(10):2206-2215. PubMed ID: 32894652
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.
Fang X; Wang J; Chen J; Zhuang M; Huang T; Chen Z; Huang Y; Zheng B; Wang X
Front Genet; 2022; 13():851390. PubMed ID: 35464847
[No Abstract] [Full Text] [Related]
5. Expression and prognostic value of Chromobox family members in gastric cancer.
Ma T; Ma N; Chen JL; Tang FX; Zong Z; Yu ZM; Chen S; Zhou TC
J Gastrointest Oncol; 2020 Oct; 11(5):983-998. PubMed ID: 33209492
[TBL] [Abstract][Full Text] [Related]
6. Expression and Prognostic Value of Chromobox Family Proteins in Esophageal Cancer.
Liu J; Shen H; Chen X; Ding Y; Wang H; Xu N; Teng L
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140750
[TBL] [Abstract][Full Text] [Related]
7. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma.
Gong W; Dai W; Wei H; Chen Y; Zheng Z
Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of distinct CBX family members in breast cancer.
Liang YK; Lin HY; Chen CF; Zeng D
Oncotarget; 2017 Nov; 8(54):92375-92387. PubMed ID: 29190923
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma.
Zhu Y; Pu Z; Li Z; Lin Y; Li N; Peng F
Front Oncol; 2021; 11():700528. PubMed ID: 34395271
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer.
Hu K; Yao L; Xu Z; Yan Y; Li J
Front Cell Dev Biol; 2022; 10():832354. PubMed ID: 35155439
[No Abstract] [Full Text] [Related]
11. Comprehensive bioinformatics analysis of the expression, prognostic value, and immune infiltration of chromobox family members in cervical cancer.
Liao D; Liu X; He L; Yao Y; Yuan X; Feng P; Li C; Liu Y
Iran J Basic Med Sci; 2023 Apr; 26(4):468-477. PubMed ID: 37009012
[TBL] [Abstract][Full Text] [Related]
12. An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma.
Zhou F; Chen L; Lu P; Cao Y; Deng C; Liu G
BMC Cancer; 2023 Jul; 23(1):641. PubMed ID: 37430195
[TBL] [Abstract][Full Text] [Related]
13. CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.
Yang Y; Hu Z; Sun H; Yu Q; Yang L; Yin F; Sun Y; Pu L; Zhu X; Li S; Chen X; Zhao Y
Onco Targets Ther; 2021; 14():5477-5492. PubMed ID: 34992383
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
Li X; Gou J; Li H; Yang X
Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
[TBL] [Abstract][Full Text] [Related]
15. Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma.
Li D; Liu Y; Hao S; Chen B; Li A
J Clin Lab Anal; 2020 Dec; 34(12):e23537. PubMed ID: 32860274
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox Family Members in Colorectal Cancer.
Li Q; Pan Y; Cao Z; Zhao S
Front Oncol; 2020; 10():582667. PubMed ID: 33014884
[No Abstract] [Full Text] [Related]
17. Significance of chromobox protein (CBX) expression in diffuse LBCL.
Hu CY; Li X; Zeng T; Ye DM; Li YK; Yan HX
Gene; 2022 Mar; 813():146092. PubMed ID: 34896523
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
[TBL] [Abstract][Full Text] [Related]
19. Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
Hu K; Yao L; Zhou L; Li J
Int J Gen Med; 2022; 15():2463-2474. PubMed ID: 35282653
[TBL] [Abstract][Full Text] [Related]
20. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
